Freedom Biosciences
Biotechnology Research
Overview
Freedom Biosciences is a clinical-stage biotechnology platform developing next-generation neuropsychiatric therapeutics. Through its discovery platform, Freedom Biosciences has identified the most efficacious combinations of chemicals to advance the safety and therapeutic profiles of existing therapeutics. With programs with clinical data and multiple exploratory programs, Freedom Biosciences has a diverse portfolio of assets that are positioned to significantly change the way we treat mental health indications.
Freedom Biosciences is co-founded by Dr. John Krystal and Dina Burkitbayeva. Dr. John Krystal is the Chair of the Department of Psychiatry at Yale University and Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital. Dina Burkitbayeva is a co-founder of PsyMed Ventures.
Tagline
Next generation psychedelic therapeutics biotech platform
EMPLOYEES
2-10 employees
FOUNDED
2021
HQ
—
TYPE
Privately Held
Location
- Street
- —
- City
- —
- Region
- —
- Postal code
- —
- Country
- —
Email patterns
See email patterns for Freedom Biosciences
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
freedombio.co is the website of Freedom Biosciences.
What is the industry of the company?
Freedom Biosciences (freedombio.co) is in the Biotechnology Research industry.
When was the company founded?
Freedom Biosciences (freedombio.co) was founded in 2021.
How many employees does the company have?
Freedom Biosciences (freedombio.co) has 2-10 employees.
What is the company type?
The company type of Freedom Biosciences (freedombio.co) is Privately Held.
What are the social media accounts of the company?
The social media account of Freedom Biosciences (freedombio.co) is LinkedIn.
Social media